Navigation Links
Prime Therapeutics Receives TIPPS Certification
Date:9/6/2007

ted to the employer's contract. It also includes rigorous audit rights to guarantee compliance. TIPPS certification requires an annual renewal process.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 12.5 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by ten Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

Transparency in Pharmaceutical Purchasing Standards and TIPPS are service marks of Health Care Policy Roundtable, LLC.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Aggressiveness is a prime heart disease risk
3. Prime Minister Manmohan Against Incentive-Based Population Control
4. Prime Minister Declares War on AIDS
5. Indian Prime Minister undergoes Minor Surgery in AIIMS
6. Movie Smoking Is The Prime Triggering Factor For Adolescents
7. Plastic Surgery Is Primetime among Ethnic Groups
8. Prime Suspect Apprehended in AIIMS Question Paper Leak
9. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
10. Prime Minister Asks Medicos to End Strike
11. Prime Minister Reassure Medical Students Asks them to Call off Strike
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...g to a new study by researchers in National Instit...g clinical signs of dementia increases with the nu...e brain. Among their findings is the observation ...ase and cerebral infarcts (strokes) is the most co...
...h International Congress on Hair Research will be ...e largest gathering of hair experts, with clinicia...disease and treatment. Whether long or short, thi... a person emotionally. Hair loss is not simply a m...
World Blood Donor Day
...known generically as anidulafungin was shown to be...nvasive candidiasis, a potentially fatal blood inf...een hobbled. This is according to a research by Dr...n Camden, New Jersey, and colleagues who published...
Other Medicine News:Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:World Largest Hair Congress Convene in Vancouver 2Health News:World Blood Donor Day 2Health News:New Anti Fungal Drug Eraxis as Good as the Older Medicine 2
(Date:10/13/2008)...nd to Have Higher Sensitivity and Specificity, th...d was the preferred test in all ph...t. 13 /- AT First Diagnostic LLC an,e...stic test kits, today,announced that a recent eval... of Research of the FirstVue(TM) HBSAG Test, was r...
(Date:10/12/2008)...s thin struts designed for more uniform drug ..., and WASHINGTON, Oct. 12 /...y announced comprehensive data from,the TAXUS ATLA...e,multi-center, single-arm, historically controll...Paclitaxel-Eluting Stent System in a variety of,le...
(Date:10/10/2008)...- Inverness Medical,Innovat...ar-patient,diagnostics, monitoring and health mana...the Secretary-General of the United Nations, as pa... the world,s leading,research-based and generic ph...together with senior officials from the United Nat...
(Date:10/9/2008)...sed Sales and Marketing Efforts to Accelerate ..., MENLO PARK, Calif., Oct. 9 /- Eval... for the percutaneous repair of cardiac valves,ha...with the appointment of,Sean Cleary as senior vice...ris Richardson, as vice president of sales., "The...
Breaking Medicine Technology:Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys 24981 1Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys 24981 2AMT to Release Half Year 2008 Results on August 13 2008 6928 1Reminder 3A Webcast Alert 3A Transgenomic Inc Announces Second Quarter 2008 Earnings Release Conference Call Webcast 6927 1Vion Reports 2008 Second Quarter and Six Month Results 24975 1Vion Reports 2008 Second Quarter and Six Month Results 24975 2Vion Reports 2008 Second Quarter and Six Month Results 24975 3Vion Reports 2008 Second Quarter and Six Month Results 24975 4Vion Reports 2008 Second Quarter and Six Month Results 24975 5Vion Reports 2008 Second Quarter and Six Month Results 24975 6
...1 Phase III Study Results Presented At ASCO -- , C...tment with,pegylated interferon alfa-2b in stage I... on relapse-free survival (RFS),according to the ...ed in patients with stage III melanoma. Results of...tion for the Research and,Treatment of Cancer (EOR...
... Affiliated Physicians Participate in ASCO,Proceed...ding cancer,researcher affiliated with the US Onco...ndomized, multicenter phase III trial,that compare...o,regimens of adjuvant therapy for patients with h...iven in an oral presentation by Dr.,David Loesch o...
Other Medicine Technology:Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5
Integrate RFID and bar code technology with the new DR1000 Dual RFID/Bar Code Reader by Precision Dynamics Corporation (PDC). It provides an easy migration from bar codes to RFID tags for healthcare
VerdaSees Navigaton™ software facilitates real time information collection. It is composed of two modules: the first module is a software link between various RFID reader devices and the databa
The AeroScout Engine is a core software component of the AeroScout Visibility System, which enables location-based applications in a wireless LAN environment. Core capabilities of the AeroScout Engin
...a wandering resident from leaving a facility undet... typically have been diagnosed with dementia, Alzh...-risk residents wear a small Watchlet™ brace...e discreetly secured by WatchMate monitors. When a...
Medicine Products: